Online citations, reference lists, and bibliographies.
← Back to Search

Development Of Megestrol Acetate Solid Dispersion Nanoparticles For Enhanced Oral Delivery By Using A Supercritical Antisolvent Process

Eun-sol Ha, J. Kim, I. Baek, Jin-Wook Yoo, Yunjin Jung, H. Moon, M. Kim
Published 2015 · Materials Science, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
In the present study, solid dispersion nanoparticles with a hydrophilic polymer and surfactant were developed using the supercritical antisolvent (SAS) process to improve the dissolution and oral absorption of megestrol acetate. The physicochemical properties of the megestrol acetate solid dispersion nanoparticles were characterized using scanning electron microscopy, differential scanning calorimetry, powder X-ray diffraction, and a particle-size analyzer. The dissolution and oral bioavailability of the nanoparticles were also evaluated in rats. The mean particle size of all solid dispersion nanoparticles that were prepared was <500 nm. Powder X-ray diffraction and differential scanning calorimetry measurements showed that megestrol acetate was present in an amorphous or molecular dispersion state within the solid dispersion nanoparticles. Hydroxypropylmethyl cellulose (HPMC) solid dispersion nanoparticles significantly increased the maximum dissolution when compared with polyvinylpyrrolidone K30 solid dispersion nanoparticles. The extent and rate of dissolution of megestrol acetate increased after the addition of a surfactant into the HPMC solid dispersion nanoparticles. The most effective surfactant was Ryoto sugar ester L1695, followed by D-α-tocopheryl polyethylene glycol 1000 succinate. In this study, the solid dispersion nanoparticles with a drug:HPMC:Ryoto sugar ester L1695 ratio of 1:2:1 showed >95% rapid dissolution within 30 minutes, in addition to good oral bioavailability, with approximately 4.0- and 5.5-fold higher area under the curve (0–24 hours) and maximum concentration, respectively, than raw megestrol acetate powder. These results suggest that the preparation of megestrol acetate solid dispersion nanoparticles using the supercritical antisolvent process is a promising approach to improve the dissolution and absorption properties of megestrol acetate.
This paper references
10.1016/j.ijpharm.2014.11.060
Improved oral absorption of dutasteride via Soluplus®-based supersaturable self-emulsifying drug delivery system (S-SEDDS).
D. Lee (2015)
10.1016/j.ijbiomac.2014.03.006
Dissolution and oral absorption of pranlukast nanosuspensions stabilized by hydroxypropylmethyl cellulose.
I. Baek (2014)
10.1007/s12272-011-0115-2
Solid dispersion formulations of megestrol acetate with copovidone for enhanced dissolution and oral bioavailability
Soon Wook Hong (2011)
Effect of compaction pressure on the dissolution efficiency of some direct compression systems.
K. A. Khan (1972)
10.1016/J.SUPFLU.2013.12.020
A comparative evaluation between utilizing SAS supercritical fluid technique and solvent evaporation method in preparation of Azithromycin solid dispersions for dissolution rate enhancement
E. Adeli (2014)
10.1017/S1431927605500011
Characterization of Nanoparticles for Drug Delivery Applications
Z. Deng (2005)
10.1111/j.1532-5415.2000.tb04993.x
Improvement in Quality‐of‐Life Measures and Stimulation of Weight Gain After Treatment with Megestrol Acetate Oral Suspension in Geriatric Cachexia: Results of a Double‐Blind, Placebo‐Controlled Study
Shing‐shing Yeh (2000)
Development and Therapy downloaded from https://www.dovepress.com/ by 54.191.40.80 on 03-Apr-2017 For personal use only
10.2147/IJN.S26546
Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process
M. Kim (2011)
10.2147/IJN.S71891
Fabrication and evaluation of valsartan–polymer– surfactant composite nanoparticles by using the supercritical antisolvent process
M. Kim (2014)
10.1007/s40005-013-0111-2
Effect of physiochemical variables on phase solubility and dissolution behavior of indomethacin solid dispersion system
Mohanraj Palanisamy (2013)
10.1016/J.SUPFLU.2008.08.015
Encapsulation and co-precipitation processes with supercritical fluids: Fundamentals and applications
M. J. Cocero (2009)
Encapsulation and coprecipitation processes with supercritical fluids: fundamentals and applications
Mj Cocero (2009)
10.1002/bmc.2807
Rapid and sensitive LC-MS/MS method for determination of megestrol acetate in human plasma: application to a human pharmacokinetic study.
Ji-Hyung Seo (2013)
Palliative treatment of cancer anorexia with oral suspension of megestrol acetate.
M. Tomíška (2003)
10.1016/j.jconrel.2010.10.034
Nanonization of megestrol acetate by laser fragmentation in aqueous milieu.
Jean-Philippe Sylvestre (2011)
Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebocontrolled study
Ss Yeh (2000)
10.1021/IE900944Y
Nanonization of Megestrol Acetate by Liquid Precipitation
Zhibing zhang (2009)
10.1248/CPB.C14-00030
Preparation and evaluation of solid dispersion of atorvastatin calcium with Soluplus® by spray drying technique.
Eun-sol Ha (2014)
10.2147/DDDT.S84070
Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan
J. Lee (2015)
Development and Therapy downloaded from https://www.dovepress.com/ by 54.191.40.80 on 31-Mar-2017 For personal use only
10.1016/j.ijpharm.2013.01.067
Supersaturatable formulations for the enhanced oral absorption of sirolimus.
M. Kim (2013)
Drug Des Devel Ther
(2015)
10.2147/IJN.S595
Nanocrystal technology, drug delivery and clinical applications
Jens-Uwe A. H. Junghanns (2008)
10.2147/DDDT.S81253
Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs
X. Yin (2015)
10.1007/s11095-005-8635-4
Nanoparticles of Poorly Water-Soluble Drugs Prepared by Supercritical Fluid Extraction of Emulsions
B. Shekunov (2005)
10.1016/j.ijpharm.2014.06.060
Combining in vitro and in silico methods for better prediction of surfactant effects on the absorption of poorly water soluble drugs-a fenofibrate case example.
R. Berthelsen (2014)
10.2147/IJN.S44795
Influence of hydrophilic additives on the supersaturation and bioavailability of dutasteride-loaded hydroxypropyl-β-cyclodextrin nanostructures
M. Kim (2013)
10.1016/j.ijbiomac.2014.08.017
Dissolution and bioavailability of lercanidipine-hydroxypropylmethyl cellulose nanoparticles with surfactant.
Eun-sol Ha (2015)
10.3390/molecules191220325
Formulation, Characterization, and in Vivo Evaluation of Celecoxib-PVP Solid Dispersion Nanoparticles Using Supercritical Antisolvent Process
Eun-sol Ha (2014)
10.2147/DDDT.S62176
Novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting state
K. Jang (2014)
10.3109/10837459609031415
Micellization and solubilization behavior of sucrose laurate, a new pharmaceutical excipient.
P. C. Lerk (1996)
Powered by TCPDF (www.tcpdf.org)
Figure 7 Correlation between in vitro dissolution efficiency and in vivo pharmacokinetic parameters. Notes: (A) aUc; (B) c max . Abbreviations: aUc, area under the concentration-time curve; c max
10.2147/DDDT.S65561
Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose
P. M. de la Torre-Iglesias (2014)
10.1016/j.ijpharm.2010.06.016
Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
Eunbi Cho (2010)



This paper is referenced by
10.3390/antiox8110554
Preparation and Evaluation of Resveratrol-Loaded Composite Nanoparticles Using a Supercritical Fluid Technology for Enhanced Oral and Skin Delivery
Eun-sol Ha (2019)
10.1016/j.molliq.2019.111719
Solubility and modeling of telmisartan in binary solvent mixtures of dichloromethane and (methanol, ethanol, n-propanol, or n-butanol) and its application to the preparation of nanoparticles using the supercritical antisolvent technique
Eun-sol Ha (2019)
10.1016/j.molliq.2020.113264
Solubility of bisacodyl in fourteen mono solvents and N-methyl-2-pyrrolidone + water mixed solvents at different temperatures, and its application for nanosuspension formation using liquid antisolvent precipitation
S. Lee (2020)
10.7324/JAPS.2016.60516
Enhancement of dissolution rate and intestinal stability of candesartan cilexitil
Noha Desouky Fayed (2016)
10.1007/978-3-030-44984-1_1
Supercritical Fluid Technologies: A Green Solvent Approach for Pharmaceutical Product Development
Satyanarayan Pattnaik (2020)
10.1016/J.JCOU.2017.10.003
Co-precipitation of mangiferin with cellulose acetate phthalate by Supercritical antisolvent process
I. García-Casas (2017)
10.3390/pharmaceutics11030132
Overview of the Manufacturing Methods of Solid Dispersion Technology for Improving the Solubility of Poorly Water-Soluble Drugs and Application to Anticancer Drugs
P. Tran (2019)
10.3390/antiox9040342
Pure Trans-Resveratrol Nanoparticles Prepared by a Supercritical Antisolvent Process Using Alcohol and Dichloromethane Mixtures: Effect of Particle Size on Dissolution and Bioavailability in Rats
Eun-sol Ha (2020)
10.1016/j.addr.2016.01.012
Amorphous solid dispersions: Rational selection of a manufacturing process.
Teófilo Vasconcelos (2016)
10.1080/03639045.2017.1391833
Application of scCO2 technology for preparing CoQ10 solid dispersion and SFC-MS/MS for analyzing in vivo bioavailability
Rujie Yang (2018)
10.1016/J.MOLLIQ.2019.111041
Solvent effect and solubility modeling of rebamipide in twelve solvents at different temperatures
Eun-sol Ha (2019)
10.3390/molecules21020197
New Biopolymer Nanoparticles Improve the Solubility of Lipophilic Megestrol Acetate
Malwina Lachowicz (2016)
10.1002/adhm.201700433
Supercritical Fluid Technology: An Emphasis on Drug Delivery and Related Biomedical Applications
Ranjith Kumar Kankala (2017)
10.1016/J.SUPFLU.2018.04.021
Supercritical antisolvent coprecipitation mechanisms
V. Prosapio (2018)
10.22270/JDDT.V6I3.1228
VARIOUS TECHNIQUES OF BIOAVAILABILITY ENHANCEMENT: A REVIEW
A. Khan (2016)
10.1016/j.ejpb.2018.03.010
A comparison of two biorelevant in vitro drug release methods for nanotherapeutics based on advanced physiologically‐based pharmacokinetic modelling
Fabian Jung (2018)
10.1016/J.MOLLIQ.2019.111622
Equilibrium solubility and solute-solvent interactions of carvedilol (Form I) in twelve mono solvents and its application for supercritical antisolvent precipitation
Eun-sol Ha (2019)
10.3390/pr8080938
Supercritical Antisolvent Process for Pharmaceutical Applications: A Review
P. Franco (2020)
Semantic Scholar Logo Some data provided by SemanticScholar